Showing results (31-40 of 55) with videos related to
Sort By:
Pageof 6
Journal of Neuro-Oncology|January 24, 1998
Heregulins and the ErbB-2/3/4 receptors in gliomasM Westphal, L Meima, E Szonyi, et al.Gastroenterology|May 29, 2001
Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growthM Mann, H Sheng, J Shao, et al.Analytical Biochemistry|March 15, 1996
Analysis of heregulin-induced ErbB2 phosphorylation with a high-throughput Kinase receptor activation enzyme-linked immunosorbant assayM D Sadick, M X Sliwkowski, A Nuijens, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 1995
The influence of heregulins on human Schwann cell proliferationA D Levi, R P Bunge, J A Lofgren, et al.American Journal of Respiratory Cell and Molecular Biology|April 4, 2000
Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitroN V Patel, M J Acarregui, J M Snyder, et al.Seminars in Oncology|September 11, 1999
Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin)M X Sliwkowski, J A Lofgren, G D Lewis, et al.Cancer Research|March 15, 1996
Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsivenessG D Lewis, J A Lofgren, A E McMurtrey, et al.Cancer Research|November 4, 2000
Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cellsH Kurokawa, A E Lenferink, J F Simpson, et al.The Journal of Biological Chemistry|June 13, 1998
Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage displayM D Ballinger, J T Jones, J A Lofgren, et al.Proceedings of the National Academy of Sciences of the United States of America|September 2, 1997
Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4D Zhang, M X Sliwkowski, M Mark, et al.Pageof 6